A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)
Status:
Completed
Trial end date:
2003-07-01
Target enrollment:
Participant gender:
Summary
If you are a male 30 years of age or older and have a positive diagnosis of high grade (II or
III) prostate Intraepithelial Neoplasia (PIN) or have had an abnormal/suspicious prostate
biopsy, you may be eligible for this study. This is a study of an investigational medication
that may reduce high grade PIN and prevent the occurrence of prostate cancer. This study is
currently enrolling up to 500 men at approximately 60 locations in the United States.